| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/1996 | CA2172629A1 Distamycin a analogues as antitumour or antiviral agents |
| 02/21/1996 | EP0697421A1 Gas phase polymerization process |
| 02/21/1996 | EP0697414A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/21/1996 | EP0697412A1 Benzoxazolyl- and benzo-thiazolyl-oxazolidinones |
| 02/21/1996 | EP0697410A1 54-substituted alkylidene 2-(N-cyanoimino)-thiazolidin-4-one derivatives, their preparation and their use as aldose reductase inhibitors |
| 02/21/1996 | EP0697409A1 Isothiazole derivatives containing (an) iodoalkylnyl group(s), their preparation and their use as fungicide and/or bactericide |
| 02/21/1996 | EP0697408A1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists |
| 02/21/1996 | EP0697405A1 Substituted quinoline derivatives, process for their preparation and their use |
| 02/21/1996 | EP0697403A1 Derivatives of glycinamides as cholecystokinin receptor agonists |
| 02/21/1996 | EP0697397A1 L-carnitine salt and compositions containing same |
| 02/21/1996 | EP0697215A1 Digestive symptom ameliorant |
| 02/21/1996 | EP0697213A1 Deodorant cosmetic composition |
| 02/21/1996 | EP0697212A2 Deodorant cosmetic composition superior in resistance to discoloration and dispersion |
| 02/21/1996 | EP0697175A1 Method and composition for improving the weight gain of poultry |
| 02/21/1996 | EP0697169A1 Organ preservative |
| 02/21/1996 | EP0697022A1 Phosphoramidates useful as antitumor agents |
| 02/21/1996 | EP0697020A1 8-substituted xanthines as selective adenosine receptor agents |
| 02/21/1996 | EP0697019A1 Risperidone pamoate |
| 02/21/1996 | EP0697015A1 Optically active 3-(1-(alkylamino))alkyl pyrrolidines |
| 02/21/1996 | EP0696921A1 Veterinary composition containing a proton pump inhibitor |
| 02/21/1996 | EP0696918A1 Composition containing cholestyramine and method of producing the same |
| 02/21/1996 | EP0696917A1 Method and means for inhibiting posterior capsule opacification |
| 02/21/1996 | EP0614455B1 Vitamin d amide derivatives |
| 02/21/1996 | EP0588797B1 N- 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections |
| 02/21/1996 | EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers |
| 02/21/1996 | EP0474767B1 Dopamine agonists |
| 02/21/1996 | CN1117295A Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 02/21/1996 | CN1117292A Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/21/1996 | CN1117291A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl|B¨pyran-2-ones useful to treat retroviral infections |
| 02/21/1996 | CN1117290A Bicyclic carboxylic acid leukotriene B4 antagonists |
| 02/21/1996 | CN1117268A Carbostyril derivative for inhibiting production of interleukin-8 |
| 02/21/1996 | CN1117267A Synergistic compositions containing benzimidazole anthelmintics and methylenedioxyphenyl compounds |
| 02/21/1996 | CN1117050A 14 alpha, 17 alpha-ethano-16 alpha-hydroxy-estratriene |
| 02/21/1996 | CN1117048A A process for preparing an intermediate compound of the benzothiazole compounds |
| 02/21/1996 | CN1117046A Method for preparing pharmaceutically active CNS compounds |
| 02/21/1996 | CN1117045A Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
| 02/21/1996 | CN1117044A Substituted N-heteroaroaroylguanidin, preparation, pharmaceutical application and medicine containg same |
| 02/21/1996 | CN1116931A Ganlong extract and Ganlong preparation |
| 02/21/1996 | CN1116930A 1,6-diphosphofructose sodium salt capsule |
| 02/21/1996 | CN1116929A Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended caments prevention or treatment of symptoms associated with the syndrome of spontaneous or prec..... |
| 02/21/1996 | CN1116928A Ophthalmic composition |
| 02/21/1996 | CN1116927A Amino acid whole nutrient and its producing process |
| 02/21/1996 | CN1116925A Cod liver oil emulsion and its preparation |
| 02/21/1996 | CN1116924A Utilisation des acides sulfoniques comme agents antivieillissement dans une composition cosmetiqueou dermatologique |
| 02/21/1996 | CN1031061C Process for preparing of 14 alpha, 17 alpha-ethano-16 alph-hydroxy-estratriene derivatives |
| 02/21/1996 | CN1031060C Process for preparing esters |
| 02/21/1996 | CN1031059C Method for preparation of 7-oxa-bi-eycloheptyl substituted heterocyclic amide prostaglandin analogs |
| 02/21/1996 | CN1031058C Antiviral tetrahydroimidazo |1,4¨-benzodiazepin-2-ones derivatives |
| 02/21/1996 | CN1031057C Preparation of triazolo |4,3-a¨|1,4¨ benzodiazepine and thiapheno |3,2-f¨|1,2,4¨ triazolo |4,3-a¨|1,4¨diazepine derivatives |
| 02/21/1996 | CN1031056C Process for preparing 6-substituted purinyl piperazine derivatives |
| 02/21/1996 | CN1031055C Process for preparing dideoxycarbocyclic nucleosides |
| 02/21/1996 | CN1031054C Process for production of bis-(hydroxymethyl)-cyclobutyl-purines and pyrimidines |
| 02/21/1996 | CN1031053C Method for preparation of azaoxindole derivatives |
| 02/21/1996 | CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 02/21/1996 | CN1031037C Topically applied gold organic complex |
| 02/20/1996 | US5493051 Lifibrol and its use |
| 02/20/1996 | US5493046 A 1-((4-phenyl)phenyl)-methylene)imidazole |
| 02/20/1996 | US5493032 Process for the preparation of substituted difluorobenzo-1,3-dioxoles |
| 02/20/1996 | US5493030 5-substituted derivatives of mycophenolic acid |
| 02/20/1996 | US5493029 Useful in treating asthma and hypertension |
| 02/20/1996 | US5493020 Tricyclic inhibitors of the GPIIb IIIa receptor |
| 02/20/1996 | US5493019 Useful as antiinflammatory and antiproliferative agents |
| 02/20/1996 | US5493018 Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid |
| 02/20/1996 | US5493017 Ring-metalated porphyrins |
| 02/20/1996 | US5493014 Hypocariogenic hydrogenated starch hydrolysate, process for preparing it and the application of this hydrolysate |
| 02/20/1996 | US5492938 Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates |
| 02/20/1996 | US5492936 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 02/20/1996 | US5492935 Compositions comprising retinal and derivatives thereof for treatment of cosmetic or dermatologic skin disorders |
| 02/20/1996 | US5492934 Chemosensory olfactory assay for somatization disorders |
| 02/20/1996 | US5492933 Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof |
| 02/20/1996 | US5492932 Cetyl alcohol, glycolic acid, benzalkonium chloride and isopropyl alcohol; applied to surface of hands as antiseptic film or ?invisible glove?; alleviates drying of the skin |
| 02/20/1996 | US5492930 Administering 2-phenyl-1,3-propanediol monocarbamate |
| 02/20/1996 | US5492927 Non-peptide tachykinin receptor antagonists to treat allergy |
| 02/20/1996 | US5492926 Methods for inhibiting vascular smooth muscle cell proliferation and restinosis |
| 02/20/1996 | US5492924 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 02/20/1996 | US5492923 Drug for treating arterial hypertension and atherosclerosis |
| 02/20/1996 | US5492922 Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation |
| 02/20/1996 | US5492921 Preventing restenosis |
| 02/20/1996 | US5492919 Irritable bowel disorder |
| 02/20/1996 | US5492918 Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation |
| 02/20/1996 | US5492915 Substituted quinolyl compounds exhibiting selective leukotriene B4 antagonist activity |
| 02/20/1996 | US5492914 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof |
| 02/20/1996 | US5492913 N-benzylpiperazine compounds |
| 02/20/1996 | US5492912 Improves glucose tolerance |
| 02/20/1996 | US5492911 Linsidomine for the treatment for erectile dysfunctions |
| 02/20/1996 | US5492908 Antiarthritic |
| 02/20/1996 | US5492907 Antipsychotic composition and method of treatment |
| 02/20/1996 | US5492906 Derivatives of thieno-triazolo-diazepine and therapeutic compositions containing them |
| 02/20/1996 | US5492905 1-bolizazepin-2,5-diones |
| 02/20/1996 | US5492904 Treatment of hypertension and congestive heart failure |
| 02/20/1996 | US5492901 Cobranin-F injection envenomation antidote |
| 02/20/1996 | US5492900 Method for enhancing the solubility of the boron delivery drug, boronophenylalanine (BPA) |
| 02/20/1996 | US5492899 Contains carbohydrates, lipids, proteins, vitamins, minerals and rna, mono-,di and triphosphate nucleotides |
| 02/20/1996 | US5492897 Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives |
| 02/20/1996 | US5492891 Treating with human growth hormone to increase levels of insulin-like growth factor |
| 02/20/1996 | US5492713 Nutriment preparation |
| 02/20/1996 | US5492700 Cellulose esters, polyacrylic acids or esters as release-control agents |
| 02/20/1996 | US5492692 Blend of nonoxynol oligomers, polyvinylpyrrolidone and iodine |
| 02/20/1996 | US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza |
| 02/20/1996 | CA2156579A1 Method of treating vascular leak syndrome |